Digital Pharma’s new gatekeeper: AI’s rising role The AI bouncer guarding the door of healthcare information isn’t going anywhere and isn’t changing its standards.
News Patients may have quit statins after media row Coverage may have given "disproportional weight" to concerns over side effects.
R&D Allogeneic cell therapy isn’t dead, with Brian Culley Lineage Cell Therapeutics' Brian Culley discusses allogeneic cell therapy, even beyond the traditional cell therapy realm of oncology.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
